These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16116959)

  • 21. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of hypoxia on the expression of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinase mRNA in human periodontal ligament fibroblasts in vitro].
    Song AM; Hou C; Chen JF; Sun J; Tian T; Li S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Oct; 47(10):599-604. PubMed ID: 23302382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
    Kang MJ; Oh YM; Lee JC; Kim DG; Park MJ; Lee MG; Hyun IG; Han SK; Shim YS; Jung KS
    J Korean Med Sci; 2003 Dec; 18(6):821-7. PubMed ID: 14676438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
    Calikoğlu M; Unlü A; Tamer L; Ozgür E
    Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease.
    Zhang Y; Li Y; Ye Z; Ma H
    Med Sci Monit; 2020 Oct; 26():e925278. PubMed ID: 33070147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts.
    Ning W; Dong Y; Sun J; Li C; Matthay MA; Feghali-Bostwick CA; Choi AM
    Am J Respir Cell Mol Biol; 2007 Apr; 36(4):480-90. PubMed ID: 17099140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
    Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expressions of TOLL-like receptor 4 (TLR-4) and matrix metalloproteinase 9 (MMP-9)/Tissue inhibitor of metalloproteinase 1 (TIMP-1) in pulmonary blood vessels with chronic obstructive pulmonary diseases and their relationships with pulmonary vascular remodelling.
    Yu WC; Cong JP; Mi LY
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):361-367. PubMed ID: 30133616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of disequilibrium of expression of matrix metalloproteinase-2/9 and their tissue inhibitors in pathogenesis of hyperoxia-induced acute lung injury in mice].
    Zhang XF; Zhu GF; Liu S; Foda HD
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Oct; 20(10):597-600. PubMed ID: 18926070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.
    Dellalibera-Joviliano R; Jacob-Ferreira AL; Joviliano EE; Tanus-Santos JE; Evora PR
    Vasc Med; 2012 Apr; 17(2):73-8. PubMed ID: 22402936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of shuxuening injection on the levels of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in acute exacerbated chronic obstructive pulmonary disease patients].
    Wang TJ; Xie ZH; Zhao ZZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):191-4. PubMed ID: 22574591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.
    Papakonstantinou E; Karakiulakis G; Batzios S; Savic S; Roth M; Tamm M; Stolz D
    Respir Res; 2015 Jun; 16(1):78. PubMed ID: 26126526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of N-acetylcysteine on the cytokines and matrix metalloproteinases in chronic obstructive pulmonary disease rat models].
    Xu L; Cai BQ; Zhu YJ; Guo ZJ; Zhang H; Gu L; Xu XX
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):595-9. PubMed ID: 15355665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
    Xu XM; Sun TY; Lin JB; Zhang HS
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
    Higashimoto Y; Yamagata Y; Iwata T; Okada M; Ishiguchi T; Sato H; Masuda M; Itoh H
    Eur Respir J; 2005 May; 25(5):885-90. PubMed ID: 15863647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
    Chen YS; Langhammer T; Westhofen M; Lorenzen J
    Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.
    Vernooy JH; Lindeman JH; Jacobs JA; Hanemaaijer R; Wouters EF
    Chest; 2004 Dec; 126(6):1802-10. PubMed ID: 15596677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1.
    Shen DD; Yang ZH; Huang J; Yang F; Lin ZW; Ou YF; Hu MH
    Pharm Biol; 2019 Dec; 57(1):744-752. PubMed ID: 31679431
    [No Abstract]   [Full Text] [Related]  

  • 39. [Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
    Zheng Y; Ding J; Wang CL; Jiao SS; Qu LM; Bahargul ; Bao H; Chen X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):299-302. PubMed ID: 21624249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
    Lanchou J; Corbel M; Tanguy M; Germain N; Boichot E; Theret N; Clement B; Lagente V; Malledant Y
    Crit Care Med; 2003 Feb; 31(2):536-42. PubMed ID: 12576963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.